The First Principles of Radiopharmaceuticals 

Register today for a free one hour virtual educational event on Monday, December 6th, 12:00 PM EST, hosted by POINT Biopharma, the next-generation radiopharmaceutical company. 

Event Speakers

Joe 800x800

Joe McCann, Ph.D.

Joe is the CEO of POINT Biopharma. Prior to this role, Joe held various roles of increasing responsibility at the Centre for Probe Development and Commercialization (CPDC), most recently as Chief Executive Officer and President, where he led the formation and growth of the company’s contract development and manufacturing operations and the build out of radiopharmaceutical manufacturing facilities. Prior to joining CPDC, Joe was a Scientist in Pharmaceutical Development at GlaxoSmithKline, responsible for developing products across all stages of clinical development.

Joe has a Ph.D. in biochemistry from McMaster University.

Neil (Color)-1

Neil Fleshner, M.D.

Neil is the CMO of POINT Biopharma. Neil graduated with a medical degree from the University of Toronto in 1988. He completed specialty training in urologic surgery and oncology from 1993 to 1996, received a Master’s in Public Health in epidemiology from Columbia University in 1997, and completed his oncology training at Memorial Sloan-Kettering Cancer Center.

Neil is certified in both urology and epidemiology. Neil is also a Professor of Surgery at the University of Toronto. In the past, he has served as the Head of the Division of Urology at the University Health Network, and the Head of Genitourinary Cancer Site group at the Princess Margaret Hospital. He also holds the prestigious Love Chair in prostate cancer prevention at Princess Margaret Hospital.